
Merck & Co., Inc. statistics
$147.76+0.55%Close 13 Nov 2026
Valuation and share-price figures are struck on the latest close (13 Nov 2026); the others are read from the company's reports. A figure that cannot be worked out, such as a P/E after a loss, is left out.
Valuation
| Enterprise value | $408.5B |
|---|
| EV / EBITDA | 14.45 |
|---|
| EV / sales | 6.06 |
|---|
Share price
| Latest close | $147.76 |
|---|
| Day's change | +0.6% |
|---|
| 52-week high | $156.92 |
|---|
| 52-week low | $90.90 |
|---|
| From 52-week high | −5.8% |
|---|
| Return · 1 month | +1.2% |
|---|
| Return · 3 months | −0.8% |
|---|
| Return · year to date | +40.4% |
|---|
| Return · 1 year | +61.6% |
|---|
| Beta · 1 year against the S&P 500 | 0.19 |
|---|
| 50-day average | $146.13 |
|---|
| 200-day average | $128.65 |
|---|
| RSI 14 | 52.5 |
|---|
| Average volume · 20 sessions | 9.6M |
|---|
Margins and returns
For fiscal 2025, as filed.
| Gross margin | 74.8% |
|---|
| Operating margin | 34.5% |
|---|
| Net margin | 28.1% |
|---|
| Free cash flow margin | 19.0% |
|---|
| Return on equity | 36.9% |
|---|
| Return on assets | 15.3% |
|---|
| Return on invested capital | 21.9% |
|---|
| Return on capital employed | 22.7% |
|---|
| Stock-based compensation / revenue | 1.3% |
|---|
Financial position
At the end of fiscal 2025.
| Cash and equivalents | $14.56B |
|---|
| Total debt | $50.49B |
|---|
| Net debt | $35.93B |
|---|
| Current ratio | 1.54 |
|---|
| Debt / equity | 0.96 |
|---|
| Net debt / EBITDA | 1.27 |
|---|
| Interest coverage | 16.52 |
|---|
Shares and dividends
For fiscal 2025, as filed.
| Diluted shares | 2.5B |
|---|
| Net share repurchases | $4.99B |
|---|
| Dividends per share | $3.28 |
|---|
| Dividend payout | 44.8% |
|---|
Taxes
For fiscal 2025, as filed.
| Income tax expense | $2.80B |
|---|
| Effective tax rate | 13.3% |
|---|
MRK in the terminal
Valuation against the company's own history, a cash-flow valuation, peers, charts and alerts.